Typical and Atypical Antipsychotics Do Not Differ Markedly in Their Reversibility of Antagonism of the Dopamine D2 Receptor

International Journal of Neuropsychopharmacology - United Kingdom
doi 10.1017/s1461145713000801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Antagonism of Dopamine D2 Receptor/ -Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

Biological Psychiatry
Biological Psychiatry
2013English

How Do Antipsychotics Exert Their Effects on Dopamine Receptor Subtypes?

Folia Pharmacologica Japonica
Pharmacology
1998English

Serial Quelling: The Typical Use of Atypical Antipsychotics?

Australian and New Zealand Journal of Psychiatry
MedicinePsychiatryMental Health
2019English

Differential Modulation of Reinforcement Learning by D2 Dopamine and NMDA Glutamate Receptor Antagonism

Journal of Neuroscience
Neuroscience
2014English

Reply to ‘Antipsychotics With Similar Association Kinetics at Dopamine D2 Receptors Differ in Extrapyramidal Side-Effects’

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Effects of Dopamine D2/D3 Receptor Antagonism on Human Planning and Spatial Working Memory

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2017English

Dopamine Receptor Heteromers: Biasing Antipsychotics

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2018English

Review of the Efficacy of Placebo in Comparative Clinical Trials Between Typical and Atypical Antipsychotics

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy